Over 30 years ago, our founder pioneered the development of the first device capable of precisely controlling oxygen levels in an incubator. This simple innovation revealed a critical gap in cell processing technology: existing methods were unable to provide cells with physiologically relevant conditions. This realization became the cornerstone of the Cytocentric® platform: where systems are built around the needs of cells.

Addressing this critical need led to the creation of the Xvivo System®, a modular and portable aseptic space designed to envelop entire protocols in an optimal, continuously controlled environment. With customizable modules and design, the Xvivo System® seamlessly accommodates diverse cell production processes and readily adapts to protocol adjustments and dynamic pipelines.

The introduction of this groundbreaking technology has catalyzed transformative advancements in drug design, medicine, and cell therapies. Users have experienced revolutionary improvements in their data by processing cells within a fully physiological environment for the first time, marking a profound shift in scientific and medical capabilities.